Millennium Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-97,700
| Closed | -$1.36M | – | 7270 |
|
|
2022
Q3 | $1.36M | Buy |
+97,700
| New | +$1.57M | ﹤0.01% | 4078 |
|
|
2017
Q1 | – | Sell |
-53,000
| Closed | -$5.76M | – | 3937 |
|
|
2016
Q4 | $5.76M | Buy |
53,000
+30,000
| +130% | +$3.57M | 0.01% | 1242 |
|
|
2016
Q3 | $3.79M | Buy |
+23,000
| New | +$3.63M | 0.01% | 1518 |
|
|
2016
Q2 | – | Sell |
-15,000
| Closed | -$1.93M | – | 3698 |
|
|
2016
Q1 | $1.93M | Buy |
+15,000
| New | +$1.77M | ﹤0.01% | 1796 |
|
|
2015
Q4 | – | Sell |
-35,000
| Closed | -$5.8M | – | 3853 |
|
|
2015
Q3 | $5.8M | Buy |
+35,000
| New | +$7.7M | 0.01% | 1245 |
|
|
2015
Q2 | – | Sell |
-70,000
| Closed | -$19.7M | – | 3971 |
|
|
2015
Q1 | $19.7M | Buy |
70,000
+39,000
| +126% | +$8.45M | 0.04% | 668 |
|
|
2014
Q4 | $4.84M | Buy |
31,000
+8,600
| +38% | +$1.59M | 0.01% | 1413 |
|
|
2014
Q3 | $5.3M | Sell |
22,400
-39,300
| -64% | -$10M | 0.01% | 1262 |
|
|
2014
Q2 | $14.6M | Buy |
61,700
+13,700
| +29% | +$3.61M | 0.04% | 628 |
|
|
2014
Q1 | $15.8M | Buy |
+48,000
| New | +$16.2M | 0.05% | 563 |
|
Millennium Management's ICPT Position: Q4 2023 in Review
Millennium Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 179,333 shares — an estimated $3.32M sold.
Millennium Management first reported a position in ICPT in Q2 2013 and held it in 35 quarters. The position peaked at $97M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Millennium Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Millennium Management sold 179,333 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3.32M.
- Millennium Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
- Millennium Management's Intercept Pharmaceuticals, Inc. position peaked at $97M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.